🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
ARC
$ARCT
🔒 US EquitiesArcturus Therapeutics Holdings
AVG HISTORICAL GAP
+3.47%
MAX GAP RECORD
+24.52%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $ARCT
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$ARCT
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 09, 2026 Earnings Release 2026-11-09 (AFTER CLOSE (21:00)) | 🔮 UPCOMING 🔒 |
| Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE) |
+6.41%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
-7.64%
|
| Mar 03, 2026 Earnings Release 2026-03-03 (AFTER CLOSE) |
-5.06%
|
| Nov 10, 2025 Earnings Release 2025-11-10 (AFTER CLOSE) |
+0.80%
|
| Aug 11, 2025 Earnings Release 2025-08-11 (AFTER CLOSE) |
+7.29%
|
| May 12, 2025 Earnings Release 2025-05-12 (AFTER CLOSE) |
+10.35%
|
| Mar 06, 2025 Earnings Release 2025-03-06 (AFTER CLOSE) |
-7.33%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
8.6%
Bullish Gaps (7)
Bearish Gaps (6)
Neutral / Flat (1)
📖 Intelligence Summary
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗